For adenocarcinoma in the lung with the EGFR-mutant strain, the induction of ferroptosis halts the progression of cancer upon the administration of Vorinostat, a histone deacetylase inhibitor that mediates decreased SLC7A11 expression [124]. The gene discussed is SLC7A11; the disease is cancer.